Cite

HARVARD Citation

    Accortt, N. et al. (2016). Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease‐Modifying Antirheumatic Drugs. Arthritis & rheumatology. 68 (1), pp. 67-76. [Online]. 
  
Back to record